Literature DB >> 10480543

Infectious diarrhea.

L Goodman1, J Segreti.   

Abstract

Infectious diarrhea is an extremely common illness that affects millions of Americans annually. For most patients, the illness is a self-limited one. Its major risk is dehydration. However, for some patients, diarrhea can lead to severe dehydration or be associated with bacteremia and metastatic infection. Patients with these conditions require prompt treatment. A large number of organisms have been associated with diarrhea in humans, and most laboratories routinely screen for Salmonella, Shigella, and Campylobacter. Other bacteria, parasites, and viruses account for a significant percentage of diarrhea cases and frequently go undetected. This article summarizes many of these pathogens and describes the settings in which they can be acquired. Food distribution networks have made the delivery of previously rare foods to remote areas a commonplace occurrence; this has also led to new challenges in the diagnosis and prevention of food-borne illnesses. Outbreaks of diarrhea now frequently extend across many states. The identification of a rare strain of a bacterial pathogen or changes in the isolation rate of common pathogens may be early clues to the cause of such an ongoing outbreak. Most enteric pathogens cause disease by either stimulating the secretion of fluids at the level of the small bowel or by irritating and invading the colon. Organisms that cause disease by the latter mechanism have the potential to invade the blood stream and spread to other parts of the body, including the bones and the central nervous system. Several organisms have been associated with specific postinfectious syndromes that are responsible for additional morbidity and mortality. The antibiotic resistance of bacterial pathogens has been increasing, and this has a limiting effect on the empiric treatment choices available for suspected bacterial diarrhea. Careful attention to local sensitivity patterns and appropriate testing of the patient's isolate are among the important factors that lead to successful treatment decisions.

Entities:  

Mesh:

Year:  1999        PMID: 10480543      PMCID: PMC7130349          DOI: 10.1016/s0011-5029(99)90000-7

Source DB:  PubMed          Journal:  Dis Mon        ISSN: 0011-5029            Impact factor:   3.800


  71 in total

Review 1.  An outbreak of extended-spectrum, beta-lactamase-producing Salmonella senftenberg in a burns ward.

Authors:  G Revathi; K P Shannon; P D Stapleton; B K Jain; G L French
Journal:  J Hosp Infect       Date:  1998-12       Impact factor: 3.926

2.  Shigella and the fluorinated quinolones.

Authors:  M Ballal; A Chandran; M Mathew; P G Shivananda
Journal:  Indian J Pathol Microbiol       Date:  1998-10       Impact factor: 0.740

3.  The increasing incidence of the hemolytic-uremic syndrome in King County, Washington: lack of evidence for ascertainment bias.

Authors:  P I Tarr; M A Neill; J Allen; C J Siccardi; S L Watkins; R O Hickman
Journal:  Am J Epidemiol       Date:  1989-03       Impact factor: 4.897

4.  Fecal leukocytes in diarrheal illness.

Authors:  J C Harris; H L Dupont; R B Hornick
Journal:  Ann Intern Med       Date:  1972-05       Impact factor: 25.391

Review 5.  Epidemiology of travelers' diarrhea: current perspectives.

Authors:  K L MacDonald; M L Cohen
Journal:  Rev Infect Dis       Date:  1986 May-Jun

6.  The risk of endothelial infection in adults with salmonella bacteremia.

Authors:  P S Cohen; T F O'Brien; S C Schoenbaum; A A Medeiros
Journal:  Ann Intern Med       Date:  1978-12       Impact factor: 25.391

7.  Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients.

Authors:  L V McFarland; C M Surawicz; W E Stamm
Journal:  J Infect Dis       Date:  1990-09       Impact factor: 5.226

8.  A campylobacter outbreak associated with stir-fried food.

Authors:  M R Evans; W Lane; J A Frost; G Nylen
Journal:  Epidemiol Infect       Date:  1998-10       Impact factor: 2.451

9.  Hemolytic-uremic syndrome after shigellosis. Relation to endotoxemia and circulating immune complexes.

Authors:  F Koster; J Levin; L Walker; K S Tung; R H Gilman; M M Rahaman; M A Majid; S Islam; R C Williams
Journal:  N Engl J Med       Date:  1978-04-27       Impact factor: 91.245

10.  Application of rejection criteria for stool ovum and parasite examinations.

Authors:  A J Morris; M L Wilson; L B Reller
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

View more
  5 in total

1.  Bacterial Infections of the Colon.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  2000-06

2.  Cholera toxin induces malignant glioma cell differentiation via the PKA/CREB pathway.

Authors:  Yan Li; Wei Yin; Xia Wang; Wenbo Zhu; Yijun Huang; Guangmei Yan
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-06       Impact factor: 11.205

3.  Cholera toxin inhibits human hepatocarcinoma cell proliferation in vitro via suppressing ATX/LPA axis.

Authors:  Qi Xia; An-mei Deng; Shan-shan Wu; Min Zheng
Journal:  Acta Pharmacol Sin       Date:  2011-07-18       Impact factor: 6.150

4.  Lysophosphatidic acid inhibits cholera toxin-induced secretory diarrhea through CFTR-dependent protein interactions.

Authors:  Chunying Li; Keanna S Dandridge; Anke Di; Kevin L Marrs; Erica L Harris; Koushik Roy; John S Jackson; Natalia V Makarova; Yuko Fujiwara; Patricia L Farrar; Deborah J Nelson; Gabor J Tigyi; Anjaparavanda P Naren
Journal:  J Exp Med       Date:  2005-10-03       Impact factor: 14.307

Review 5.  Laboratory approaches to infectious diarrhea.

Authors:  D K Turgeon; T R Fritsche
Journal:  Gastroenterol Clin North Am       Date:  2001-09       Impact factor: 3.806

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.